Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpFinancial_Report.xls
10-Q - FORM 10-Q - Raptor Pharmaceutical Corpd326749d10q.htm
XML - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpR6.htm
XML - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpR8.htm
XML - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpR5.htm
XML - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpR7.htm
XML - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpR1.htm
XML - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpR4.htm
XML - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpR9.htm
XML - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpR3.htm
XML - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpR12.htm
XML - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpR11.htm
XML - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpR16.htm
XML - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpR17.htm
XML - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpR14.htm
XML - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpR18.htm
XML - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpR19.htm
XML - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpR10.htm
XML - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpR15.htm
EX-32.1 - CERTIFICATION OF CHRISTOPHER M. STARR, PH.D AND KIM R. TSUCHIMOTO - Raptor Pharmaceutical Corpd326749dex321.htm
EX-31.2 - CERTIFICATION OF KIM R. TSUCHIMOTO, CHIEF FINANCIAL OFFICER - Raptor Pharmaceutical Corpd326749dex312.htm
EX-10.1 - COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT - Raptor Pharmaceutical Corpd326749dex101.htm
XML - IDEA: XBRL DOCUMENT - Raptor Pharmaceutical CorpR2.htm
EX-31.1 - CERTIFICATION OF CHRISTOPHER M. STARR, PH.D., CHIEF EXECUTIVE OFFICER - Raptor Pharmaceutical Corpd326749dex311.htm
v2.4.0.6
Accrued Liabilities
6 Months Ended
Feb. 29, 2012
Accrued Liabilities [Abstract]  
Accrued Liabilities

(6) ACCRUED LIABILITIES

Accrued liabilities consisted of:

 

$1,658,386 $1,658,386
     February 29,
2012
     August 31,
2011
 

Clinical trial costs

   $ 1,320,554       $ 1,177,859   

Accrued vacation and employee benefits

     293,586         142,678   

Accrued bonuses

     239,310         478,619   

Salaries and wages

     175,101         125,069   

Legal fees

     148,763         164,761   

Consulting—general and administrative

     79,534         18,085   

Patent costs

     34,197         2,969   

Clinical trial materials

     —           125,256   

Other

     84,787         13,958   
  

 

 

    

 

 

 

Total accrued liabilities

   $ 2,375,832       $ 2,249,254